Steven E. Hall

2.3k total citations
40 papers, 1.5k citations indexed

About

Steven E. Hall is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Steven E. Hall has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 20 papers in Organic Chemistry and 10 papers in Pharmacology. Recurrent topics in Steven E. Hall's work include Chemical Synthesis and Analysis (8 papers), Heat shock proteins research (7 papers) and Computational Drug Discovery Methods (6 papers). Steven E. Hall is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Heat shock proteins research (7 papers) and Computational Drug Discovery Methods (6 papers). Steven E. Hall collaborates with scholars based in United States, Malaysia and Sweden. Steven E. Hall's co-authors include William Roush, Paul M. Steed, Amy F. Barabasz, John W. Rice, Lawrence M. Ballas, Xianfeng Li, Melanie A Rehder Silinski, James M. Veal, James P. Tam and Leonard L. Winneroski and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Cancer Research.

In The Last Decade

Steven E. Hall

40 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven E. Hall United States 20 952 574 139 129 126 40 1.5k
Nigel J. Liverton United States 24 726 0.8× 711 1.2× 103 0.7× 121 0.9× 201 1.6× 61 1.8k
Anne G. Graham United States 10 804 0.8× 502 0.9× 163 1.2× 69 0.5× 230 1.8× 16 1.3k
John H. Hutchinson United States 26 882 0.9× 654 1.1× 279 2.0× 146 1.1× 147 1.2× 90 1.9k
William Seibel United States 22 943 1.0× 438 0.8× 97 0.7× 89 0.7× 176 1.4× 66 1.6k
Alfred P. Spada United States 22 664 0.7× 789 1.4× 70 0.5× 70 0.5× 172 1.4× 44 1.8k
Pier F. Cirillo United States 16 1.0k 1.1× 777 1.4× 100 0.7× 128 1.0× 260 2.1× 30 1.7k
Eugene L. Stewart United States 20 870 0.9× 377 0.7× 157 1.1× 186 1.4× 229 1.8× 47 2.2k
Elizabeth A. Lunney United States 25 1.0k 1.1× 583 1.0× 118 0.8× 60 0.5× 217 1.7× 59 1.8k
Laurie Churchill United States 13 686 0.7× 260 0.5× 165 1.2× 156 1.2× 263 2.1× 20 1.3k
John R. Regan United States 13 997 1.0× 512 0.9× 83 0.6× 83 0.6× 280 2.2× 19 1.5k

Countries citing papers authored by Steven E. Hall

Since Specialization
Citations

This map shows the geographic impact of Steven E. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven E. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven E. Hall more than expected).

Fields of papers citing papers by Steven E. Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven E. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven E. Hall. The network helps show where Steven E. Hall may publish in the future.

Co-authorship network of co-authors of Steven E. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Steven E. Hall. A scholar is included among the top collaborators of Steven E. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven E. Hall. Steven E. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mihai, D., Steven E. Hall, Haiteng Deng, Christopher J. Welch, & Akira Kawamura. (2015). Benzophenone and its analogs bind to human glyoxalase 1. Bioorganic & Medicinal Chemistry Letters. 25(22). 5349–5351. 4 indexed citations
2.
Huang, Kenneth H., Thomas E. Barta, John W. Rice, et al.. (2012). Discovery of novel aminoquinazolin-7-yl 6,7-dihydro-indol-4-ones as potent, selective inhibitors of heat shock protein 90. Bioorganic & Medicinal Chemistry Letters. 22(7). 2550–2554. 12 indexed citations
3.
Barta, Thomas E., Amy F. Barabasz, Briana Foley, et al.. (2009). Novel carbazole and acyl-indole antimitotics. Bioorganic & Medicinal Chemistry Letters. 19(11). 3078–3080. 21 indexed citations
4.
Chandarlapaty, Sarat, Ayana Sawai, Qing Ye, et al.. (2008). SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase–Dependent Cancers. Clinical Cancer Research. 14(1). 240–248. 144 indexed citations
5.
6.
Fadden, Patrick, Amy F. Barabasz, Briana Foley, et al.. (2006). A novel, orally active, small molecule Hsp90 inhibitor.. Cancer Research. 66. 1304–1304. 1 indexed citations
7.
Hall, Steven E.. (2006). Chemoproteomics-driven drug discovery: addressing high attrition rates. Drug Discovery Today. 11(11-12). 495–502. 29 indexed citations
8.
Das, Jagabandhu, S. David Kimball, Steven E. Hall, et al.. (2002). Molecular design and structure–Activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664. Bioorganic & Medicinal Chemistry Letters. 12(1). 45–49. 10 indexed citations
9.
Li, Xianfeng, Lianshan Zhang, Wei Zhang, Steven E. Hall, & James P. Tam. (2000). Solid-Phase Synthesis of 1,2,3,4-Tetrahydro-β-carboline-Containing Peptidomimetics. Organic Letters. 2(20). 3075–3078. 19 indexed citations
10.
Mullins, Leisha S., et al.. (2000). d-Ala–d-X ligases: evaluation of d-alanyl phosphate intermediate by MIX, PIX and rapid quench studies. Chemistry & Biology. 7(7). 505–514. 19 indexed citations
11.
Hall, Steven E.. (1998). Recent advances in solid phase synthesis. Molecular Diversity. 4(2). 131–142. 11 indexed citations
12.
Hall, Steven E.. (1997). The future of combinatorial chemistry as a drug discovery paradigm.. Pharmaceutical Research. 14(9). 1104–1105. 7 indexed citations
13.
Jirousek, Michael R., James R. Gillig, David A. Neel, et al.. (1995). Synthesis of bisindolylmaleimide macrocycles. Bioorganic & Medicinal Chemistry Letters. 5(18). 2093–2096. 12 indexed citations
14.
Misra, Raj N., Philip M. Sher, Manorama M. Patel, et al.. (1992). Thromboxane receptor antagonist BMS-180291: A new pre-clinical lead. Bioorganic & Medicinal Chemistry Letters. 2(1). 73–76. 16 indexed citations
15.
Hall, Steven E.. (1991). Thromboxane A2 receptor antagonists. Medicinal Research Reviews. 11(5). 503–579. 51 indexed citations
16.
Das, Jagabandhu, Steven E. Hall, Martin F. Haslanger, et al.. (1990). 9,11-Epoxy-9-homoprosta-5-enoic acid analogs as thromboxane A2 receptor antagonists. Journal of Medicinal Chemistry. 33(6). 1741–1748. 4 indexed citations
17.
Das, Jagabandhu, Martin F. Haslanger, Don N. Harris, et al.. (1990). 7-Oxabicyclo[2.2.1]heptyl carboxylic acids as thromboxane A2 antagonists: aza .omega.-chain analogs. Journal of Medicinal Chemistry. 33(9). 2465–2476. 17 indexed citations
18.
Hall, Steven E., et al.. (1989). 9,11-Epoxy-9-homo-14-thiaprost-5-enoic acid derivatives: potent thromboxane A2 antagonists. Journal of Medicinal Chemistry. 32(5). 974–984. 12 indexed citations
19.
Roush, William & Steven E. Hall. (1981). Studies on the total synthesis of chlorothricolide: stereochemical aspects of the intramolecular Diels-Alder reactions of methyl undeca-2,8,10-trienoates. Journal of the American Chemical Society. 103(17). 5200–5211. 66 indexed citations
20.
Roush, William, Herbert R. Gillis, & Steven E. Hall. (1980). Stereoselective syntheses of substituted methyl (Z,E,E)-deca-2,7.9-trienoates and substituted methyl (Z,E,E)-undeca-2,8,10-trienoates. Tetrahedron Letters. 21(11). 1023–1026. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nigel J. Liverton Breakdown of academic impact, for papers by Anne G. Graham Breakdown of academic impact, for papers by John H. Hutchinson Breakdown of academic impact, for papers by William Seibel Breakdown of academic impact, for papers by Alfred P. Spada Breakdown of academic impact, for papers by Pier F. Cirillo Breakdown of academic impact, for papers by Eugene L. Stewart Breakdown of academic impact, for papers by Elizabeth A. Lunney Breakdown of academic impact, for papers by Laurie Churchill Breakdown of academic impact, for papers by John R. Regan
Rankless by CCL
2026